Back to Journals » Diabetes, Metabolic Syndrome and Obesity » Volume 12

An easily ignored factor for CAN-fine particulate exposure [Letter]

Authors Sun H, Liang M , Zheng N

Received 11 June 2019

Accepted for publication 16 July 2019

Published 31 July 2019 Volume 2019:12 Pages 1275—1276

DOI https://doi.org/10.2147/DMSO.S219070

Editor who approved publication: Professor Ming-Hui Zou



Hua Sun,*,1 Man Liang,*,2 Na Zheng3

1Department of Endocrinology, The Affiliated Hospital of Beihua University, Jilin City, Jilin 132011, People’s Republic of China; 2Department of Forensic Science, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, Hubei, People’s Republic of China; 3Department of Pathology, Health Science Center, Shen Zhen University, Shenzhen, Guangdong 518066, People’s Republic of China

*These authors contributed equally to this work

We read with great interest the recently published article by Vasheghani et al.1 In the article, the authors showed that the prevalence of CAN was increased with prolonged duration of DM, but not the glycemic control level.

View the original paper by Vasheghani and colleagues.

A Response to Letter has been published for this article. 

Dear editor

We read with great interest the recently published article by Vasheghani et al.1 In the article, the authors showed that the prevalence of CAN was increased with prolonged duration of DM, but not the glycemic control level. In the study, the CAN was assessed based on heart rate variation during physical examination (at rest tachycardia and orthostatic hypotension) and standard Ewing’s tests (deep-breathing and laying-to-standing tests) with bedside continuous ECG recording.

Without doubt, HRV is the popular indicator for CAN, however, there are still some influence factors, and the most easily unnoticeably one may be the air pollution or fine particles exposure. Consistent links between fine particles exposure and decreased HRV in healthy volunteers have been documented in studies.2,3 In their study, an increase in 30 mg/m3 of the average PM2.5 personal exposure in the previous 2 h decreased the pNN50 in 0.08%, which suggest short term exposure to high level of fine particles could effect the HRV or CAN.

Moreover, in the susceptible population, the individual coronary risk profiles and underlying diabetes or impaired glucose tolerance might confer reduced autonomic function of heart due to particulate air pollution exposure.46 In Vasheghani et al’s study, the HRV and other tests were set standardly, however, the PM exposure of the subjects shortly before the HRV test was ignored, which might affect the conclusion if setting the level of PM as the correction factor.

Disclosure

The authors report no conflicts of interest in this communication.

References

1. Vasheghni M, Sarvghadi F, Beyranvand MR. The association between cardiac autonomic neuropathy and diabetes control. Diabetes Metab Syndr Obes. 2019;12:581–587. doi:10.2147/DMSO.S196729

2. Fan ZT, Meng Q, Weisel C, et al. Acute exposure to elevated PM2.5 generated by traffic and cardiopulmonary health effects in healthy older adults. J Expo Sci Environ Epidemiol. 2009;19(5):525. doi:10.1038/jes.2008.46

3. Vallejo M, Ruiz S, Hermosillo AG, Borja-Aburto VH, Cárdenas M. Ambient fine particles modify heart rate variability in young healthy adults. J Expo Sci Environ Epidemiol. 2006;16(2):125–130. doi:10.1038/sj.jea.7500447

4. Sun Y, Song X, Han Y, et al. Size-fractioned ultrafine particles and black carbon associated with autonomic dysfunction in subjects with diabetes or impaired glucose tolerance in Shanghai, China. Part Fibre Toxicol. 2015;12:8. doi:10.1186/s12989-015-0084-6

5. Feng Y, Huang X, Sun H, et al. Framingham risk score modifies the effect of PM10 on heart rate variability. Sci Total Environ. 2015;523:146–151. doi:10.1016/j.scitotenv.2015.04.009

6. Zheng N. Chapter 11, Sudden death and the effects on particulate matter air pollution. In: Sudden Death, Causes, Risk Factors and Prevention. 1st. USA: Nova Science Publishers, Inc; 2013: 195–210. Available from: http://www.novapublishers.org/catalog/product_info.php?products_id=41834. Accessed July 16, 2019.

Creative Commons License © 2019 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.